<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="pixel-app" -->
<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>
<channel>
	<title>Yourlawyer.com (Deep Vein Thrombosis News)</title>
	<link>http://www.yourlawyer.com/topics/overview/deep_vein_thrombosis</link>
	<description></description>
	<pubDate>Sat, 21 Nov 2009 00:50:34 -0800</pubDate>

	<generator>pixel-app</generator>
	<language>en</language>
	
	<item>
		<title>Study Finds Ways To Improve Detection Of Blood Clots In The Lung</title>
		<link>http://www.yourlawyer.com/articles/read/11811</link>		
		<pubDate>Thu, 01 Jun 2006 00:00:00 -0700</pubDate>
		<dc:creator></dc:creator>		
		<guid isPermaLink="false">http://www.yourlawyer.com/articles/read/11811</guid>
		<description><![CDATA[A new study of a commonly used imaging test of the chest to detect potentially deadly blood clots in the lung shows that extending the scan to the legs &quot;where the clots typically originate&quot; or adding a standard clinical assessment significantly improves physicians' abilities to accurately diagnose pulmonary embolism. A sudden and potentially deadly blockage in a lung artery, pulmonary embolism affects an estimated 600,000 Americans...]]></description>
			<content:encoded><![CDATA[A new study of a commonly used imaging test of the chest to detect potentially deadly blood clots in the lung shows that extending the scan to the legs &quot;where the clots typically originate&quot; or adding a standard clinical assessment significantly improves physicians' abilities to accurately diagnose pulmonary embolism. A sudden and potentially deadly blockage in a lung artery, pulmonary embolism affects an estimated 600,000 Americans each year, making it the fourth most commonly occurring cardiovascular problem in the United States. The multicenter study was funded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH).<br /> <br /> The Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) II is the largest study ever conducted to assess the role of contrast-enhanced multidetector computed tomographic (CT) angiography for diagnosing pulmonary embolism. In the June 1, 2006, issue of the New England Journal of Medicine, PIOPED researchers from eight clinical centers report that chest CT angiography alone detects suspected pulmonary embolism in only 83 percent of patients; in contrast, combined results of the chest CT angiogram and the leg CT scan detect clots in 90 percent of patients. The researchers recommend that physicians consider additional test results before ruling out pulmonary embolism in patients whose scan does not detect clots but whose clinical assessment suggests a high likelihood of pulmonary embolism.<br /> <br /> &quot;Imaging technologies are one of the most rapidly evolving areas of medicine, and they greatly expand our ability to diagnose and treat disease,&quot; said Elias A. Zerhouni, MD, NIH Director and a board-certified radiologist. &quot;In recent years, chest CT scans have become the most widely used technique for diagnosing pulmonary embolism. But, until now, we have not had enough scientific evidence to really understand how accurate they are for detecting this often-fatal condition.&quot;<br /> <br /> Pulmonary embolism (PE) leads to death in nearly one-third of untreated cases, but therapies lower the death rate to between 3 percent and 8 percent. In nine out of 10 cases, PE begins as a clot in the deep veins of the leg, a condition known as deep vein thrombosis (DVT). The clot breaks free from the vein and travels to the lung, where it can block an artery. Commonly used treatments for both PE and DVT include anti-clotting medications and injections of clot-busting agents.<br /> <br /> &quot;There are many effective ways to prevent and treat blood-clotting diseases,&quot; noted NHLBI Director Elizabeth G. Nabel, MD. &quot;Pulmonary embolism is underdiagnosed and therefore often untreated. If detected early, however, blood clots can often be prevented from causing permanent damage or death.&quot;<br /> <br /> In PIOPED II, researchers compared the accuracy of three ways to diagnose blood clots in 824 patients suspected of having pulmonary embolism: chest CT angiogram alone, chest CT angiogram with venous-phase imaging (leg CT), and chest CT angiogram with an objective clinical assessment known as the Wells Score. The Wells Score is a validated tool to determine the likelihood that a patient has PE based on characteristics such as signs and symptoms, heart rate, and risk factors. A high score indicates that a patient has a high probability of having PE. To determine their accuracy, the tests were compared with the participants' composite results from other validated diagnostic tests for PE.<br /> <br /> Overall, the sensitivity (the ability to detect clots) of the combined chest CT and leg CT was 90 percent, compared to 83 percent sensitivity of the chest CT angiogram alone. The specificity (the ability to rule out the presence of clots) of the chest CT alone compared to the chest CT and leg CT combined was similar (about 95 percent). A high clinical probability combined with positive chest CT correctly indicated PE in 96 percent of participants. However, in patients with a high clinical probability, a negative chest CT result did not confidently rule out a diagnosis of PE, the researchers report.<br /> <br /> &quot;This study suggests that chest CT angiogram for detecting dangerous blood clots in the lung is good, but sometimes it is not enough,&quot; noted Paul D. Stein, MD, director of research education at St. Joseph Mercy Oakland Hospital in Pontiac, Michigan, professor of medicine at Wayne State University, and lead author of the paper. &quot;We can more accurately detect or rule out pulmonary embolism by taking pictures of the leg veins in addition to pictures of the lung arteries.&quot;<br /> <br /> The results of the chest CT combined with the patient's clinical probability assessment were comparable to the results from the combined chest CT and leg CT scans.<br /> <br /> &quot;Our study spells out the strengths and weaknesses of chest CTs for diagnosing pulmonary embolism, and will help guide physicians on when more tests are needed,&quot; added Stein, who also chaired the PIOPED II steering committee.<br /> <br /> During a chest CT angiogram, contrast material (dye) to make the blood vessels in the lungs more visible is injected into a vein in the patient's arm. The patient lies on a table as a machine with dozens of detectors rotates around to quickly take X-ray pictures of the blood vessels in the lungs for the chest CT or in the pelvis or thighs for the leg CT. No additional dye is needed for the leg CT, which can be performed immediately after the chest CT. A computer combines the images to make detailed pictures.<br /> <br /> CT scans are noninvasive and well tolerated by most patients. Adverse effects are rare and are primarily related to the iodine-based dye that is injected; possible complications include kidney damage in patients with kidney disease and allergic reaction. The tests involve some exposure to radiation, but the benefits outweigh the risks.<br /> <br /> Risk factors for pulmonary embolism include blood clots in the leg or a history of such problems, and certain inherited conditions that increase the risk for blood clotting. Individuals who recently have been treated for cancer, have been bedridden, or have had surgery or suffered a fracture in the past few weeks are also more likely to develop PE. Other risk factors for DVT, which can lead to PE, include sitting for long periods of time, pregnancy and the 6-week period after pregnancy, and being overweight or obese. Women who take hormone therapy or birth control pills are also at increased risk for DVT.<br /> <br /> Signs of PE include unexplained shortness of breath, pain with deep breathing, and coughing up blood. Rapid breathing and a fast heart rate can also indicate possible PE. In some cases, there are only signs of DVT, such as swelling of the leg or along the vein in the leg, pain or tenderness in one leg, feeling of increased warmth in the area of the leg that is swollen, and red or discolored skin on the affected leg. Other patients do not experience any symptoms or signs of PE or DVT.]]></content:encoded>
	</item>	
	
	<item>
		<title>Parker &amp; Waichman, LLP Files Suit Against Ortho-McNeil Pharmaceutical, Inc. on Behalf of 33-Year-Old Woman Diagnosed with Bilateral Pulmonary Embolism and Deep Venous Thrombosis After Using Ortho Evra Birth Control Patch for Two Months - JNJ</title>
		<link>http://www.yourlawyer.com/articles/read/11733</link>		
		<pubDate>Fri, 19 May 2006 00:00:00 -0700</pubDate>
		<dc:creator></dc:creator>		
		<guid isPermaLink="false">http://www.yourlawyer.com/articles/read/11733</guid>
		<description><![CDATA[Parker &amp; Waichman, LLP (www.yourlawyer.com) announced that it has filed suit against Ortho-McNeil Pharmaceutical, Inc., a division of Johnson and Johnson Inc. (NYSE:JNJ), on behalf of a 33-year-old woman and her husband. The woman suffered a bilateral pulmonary embolism and deep venous thrombosis (DVT) after using Ortho Evra for two months. The suit was filed in the United States District Court for the District of New Jersey in Newark, New...]]></description>
			<content:encoded><![CDATA[Parker &amp; Waichman, LLP (www.yourlawyer.com) announced that it has filed suit against Ortho-McNeil Pharmaceutical, Inc., a division of Johnson and Johnson Inc. (NYSE:JNJ), on behalf of a 33-year-old woman and her husband. The woman suffered a bilateral pulmonary embolism and deep venous thrombosis (DVT) after using Ortho Evra for two months. The suit was filed in the United States District Court for the District of New Jersey in Newark, New Jersey. For more information on Ortho Evra and this case, please visit www.orthopatchlawsuit.com or www.yourlawyer.com/topics/overview/Ortho_Evra_Patch<br /> <br /> In May 2005, the injured party was taken to the emergency room of Hillside Hospital with shortness of breath, chest pains, tachycardia and hypoxemia. Diagnostic tests revealed a bilateral pulmonary embolism with a large embolus in the right main pulmonary artery and right upper and right lower lobe peripheral infiltrates suspected to be pulmonary infarctions. Additional tests revealed a deep venous thrombosis of the right popliteal vein extending to the right common femoral vein. The woman was admitted to the hospital's intensive care unit where she received Coumadin and Lovenox treatment. She will likely undergo prolonged treatment with these medications, which may be necessary for the remainder of her life.<br /> <br /> On November 10, 2005, Ortho McNeil, in conjunction with the FDA, issued a warning about the increased risks of blood clots associated with Ortho Evra. In the new warning, Ortho-McNeil admitted for the first time that women who use the patch will be exposed to up to 60% more estrogen than they would be exposed to if they were taking a birth control pill with 35 micrograms of estrogen. The patch is only intended to deliver 20 micrograms of estrogen. The FDA's announcement on this warning can be found at www.fda.gov/bbs/topics/news/2005/NEW01262.html It is widely understood that increased exposure to estrogen greatly increases the risk of blood clots, which can cause serious injury or death.<br /> <br /> Pulmonary embolism is a sudden blockage in a lung artery, usually due to a blood clot that traveled to the lung from the leg, but they can also form in the pelvic vein. Pulmonary thromboembolism can be fatal or may result in pulmonary arterial obstruction, pulmonary obstruction, pulmonary infarction, chronic pulmonary hypertension, dyspenea and tachypnea. Symptoms may include shortness of breath, difficulty breathing, anxiety, chest pain, fainting and convulsions. Treatment may include long term use of anticoagulant medications and/or surgery. Recent reports have indicated that the risk of developing blood clots, pulmonary thromboembolism, heart attack and stroke may be significantly higher with the Ortho Evra patch than with oral contraceptive use.<br /> <br /> Deep venous thrombosis or DVT is a condition where a blood clot (thrombus) forms within the deep vein system. The principal veins affected are those in the calf muscles, lower abdomen, groin and inner thigh. The thrombus can interfere with circulation and it may break off and travel through the blood stream, which can cause pulmonary embolism or stroke. Treatment may include long term use of anticoagulant medications and/or surgery. The new warnings from the FDA and Ortho-McNeil indicate that the risk of developing blood clots may be significantly higher with the Ortho Evra patch than with oral contraceptives.<br /> <br /> It is alleged that Ortho-McNeil was aware of the increased medical risks associated with Ortho Evra before the drug was approved and that, once approved, the company failed to adequately warn patients about these risks. Evidence shows that the risk of blood clots, heart attack and stroke associated with Ortho Evra is significantly higher than with oral contraceptive pills. The incidence of embolisms and thrombotic injuries in Phase III trials of Ortho Evra was reportedly six times greater than the incidence of such events in oral contraceptives using the hormone levonorgestral. The FDA has logged 9,116 reports of adverse reactions to the patch in a 17 month period, whereas Ortho Tri-Cyclen, a birth control pill, only generated 1,237 adverse reports in a six year period. During a 12 month period, 44 serious injuries or deaths have been associated with Ortho Evra, whereas only 17 such reports were linked to the birth control pill during a similar time period. The pattern is further magnified when usage rates are considered: Ortho Tri-Cyclen has six times the number of users as Ortho Evra.<br /> <br /> Ortho Evra is an adhesive, transdermal birth control patch that is worn on the torso. The patch is intended to release 150 mcg of norelgestromin and 20 mcg of ethinyl estradiol into the bloodstream per 24 hours. It is replaced once a week for three weeks, and no patch is worn during the fourth week during menstruation. The regimen is then repeated. Ortho Evra was approved by the FDA in November 2001, and over 4 million women have used Ortho Evra since its approval. Ortho Evra continues to be marketed aggressively to both consumers and physicians.<br /> <br /> About Parker &amp; Waichman, LLP<br /> <br /> Parker &amp; Waichman, LLP is a leading products liability and personal injury law firm that represents plaintiffs nationwide. The firm has offices in New York and New Jersey. Parker &amp; Waichman, LLP has assisted thousands of clients in receiving fair compensation for injuries resulting from defective medications and medical devices. The firm is currently representing individuals injured by Vioxx, Bextra, Zyprexa, Ketek, ReNu with MoistureLoc, Guidant Defibrillators and many other defective drugs and medical products. For more information on Parker &amp; Waichman, LLP please visit: (www.yourlawyer.com) or call (800) LAW-INFO ((800) 529-4636).<br /> <br /> More information on this and other class actions can be found on the Class Action Newsline at www.primezone.com/ca<br /> <br /> CONTACT:&nbsp; Parker &amp; Waichman, LLP<br /> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jason Mark, Esq.<br /> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Melanie H. Muhlstock, Esq.<br /> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (800) LAW-INFO<br /> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (800) 529-4636, Toll-free<br /> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; info@yourlawyer.com<br /> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; www.yourlawyer.com<br /> ]]></content:encoded>
	</item>	
	
	<item>
		<title>Study Suggests Additional Risk Factors besides Inactivity May Trigger Deadly Blood Clots on Long Flights</title>
		<link>http://www.yourlawyer.com/articles/read/11476</link>		
		<pubDate>Sun, 12 Mar 2006 00:00:00 -0800</pubDate>
		<dc:creator></dc:creator>		
		<guid isPermaLink="false">http://www.yourlawyer.com/articles/read/11476</guid>
		<description><![CDATA[For several years, &ldquo;economy class syndrome&rdquo; has been a term used to describe life-threatening blood clots associated with restrictive seating, inactivity during long flights, and frequent flying.  A recent study published in Lancet suggests that additional conditions present during air travel may add to the risk of developing deep vein thrombosis (DVT).   When 71 volunteers were tested, it was found that certain chemicals associated...]]></description>
			<content:encoded><![CDATA[<p>For several years, &ldquo;economy class syndrome&rdquo; has been a term used to describe life-threatening blood clots associated with restrictive seating, inactivity during long flights, and frequent flying.<br /> <br /> A recent study published in Lancet suggests that additional conditions present during air travel may add to the risk of developing deep vein thrombosis (DVT). <br /> <br /> When 71 volunteers were tested, it was found that certain chemicals associated with clotting were higher during an eight-hour flight than when seated at a movie.<br /> <br /> DVT is a dangerous condition that occurs when blood flow through the deepest veins in the calf or thigh slows to the point of allowing blood clots to form. It is when a piece of one of these clots breaks off and migrates to the lung where it results in a potentially deadly pulmonary embolism.<br /> <br /> When compared to similar points during eight hours of normal daily activities or sitting in a movie theater, the chemical concentrations during air travel were always higher than either of the other situations.<br /> <br /> In addition, it was found that about 40% of the subjects carried a gene that also put them at greater risk of DVT. When other DVT risk factors were also present, the chemical concentrations were even higher.<br /> <br /> Low air pressure and in-flight oxygen levels were seen as possible reasons for some of the increased risk although restricted activity and inactivity were still regarded as the most significant factors. The study also did not rule out other factors such as stress and air pollution.<br /> <br /> Clearly, however, the fact that important chemical levels increase during air travel alone means one or more other factors are involved.<br /> <br /> Significantly, the issue of DVT and its link to air travel has been studied and analyzed before. Although prior research has been inconclusive with respect to the effect of low oxygen and air pressure levels, other factors have been considered as increasing the risk of DVT, including:<br /> </p> <ul>   <li>Inactivity during flights;</li>   <li>Restrictive seating (hence the term, &quot;Economy Class Syndrome&quot;);</li>   <li>Long flights (3,100 to 4,500 miles [1/2,500,000]; 4,500 to 6,215 [1/376,000], over 6,215 miles [1/210,000];</li>   <li>Consumption of alcoholic beverages;</li>   <li>Age - elderly passengers are at greater risk;</li>   <li>Diet - overweight passengers are more at risk;</li>   <li>Air quality - dry, recirculated air may be a factor;</li>   <li>Dehydration;</li>   <li>Constrictive clothing;</li>   <li>Smoking while in flight;</li>   <li>Recent surgery;</li>   <li>Heart failure;</li>   <li>Blood clotting abnormalities;</li>   <li>History of DVT (personal or family);</li>   <li>Pregnancy;</li>   <li>Stroke;</li>   <li>Chronic illness;</li>   <li>Some oral contraceptives (Ortho Evra Patch for example); and</li>   <li>Low cabin pressure.</li> </ul> <p>There are, however, a number of things that can be done to reduce the risk of DVT when traveling by air:<br /> </p> <ul>   <li>Book a better seat (price-wise) or a seat in a better location (by an exit);</li>   <li>Wear support stockings;</li>   <li>Avoid alcoholic beverages and other diuretic drinks such as tea and coffee containing caffeine;</li>   <li>Drink plenty of water or juice;</li>   <li>Walk up and down the cabin once an hour; and</li>   <li>Exercise - ankle circles, foot pumps, lifting toes up and down, shoulder rolls, etc.</li> </ul> <p>Current estimates of those dying each year from fatal blood clots linked to flying are as high as 300 or more. <br /> <br /> In the past few years, airlines have begun to redesign and reposition seats and to provide for addition leg room on newer planes. Older and smaller planes, however, remain problematic insofar as permitting movement is concerned. <br /> <br /> Studies also considered the benefits of recommending the use of aspirin or prescription anti-coagulants to those in high-risk categories.<br /> <br /> Symptoms of DVT include:<br /> </p> <ul>   <li>Breathlessness;</li>   <li>Lightheadedness; </li>   <li>Chest pain;</li>   <li>Tenderness in one calf that feels like an ache or tightness - pain increases when ankle is flexed;</li>   <li>Swelling or redness of leg;</li>   <li>Pain or discomfort over a deep vein; and</li>   <li>No symptoms if clot forms in a vein other than an arm or leg.</li> </ul> <p>Once DVT is suspected or diagnosed, immediate treatment is recommended. Some treatments include:<br /> </p> <ul>   <li>Get to a doctor or hospital emergency room immediately;</li>   <li>Have a Doppler (ultrasound) test done to confirm the clot;</li>   <li>Begin a regimen of blood-thinning medication; and</li>   <li>Surgical intervention.</li> </ul> <p>DVT, however, is far from the only serious medical problem associated with air travel or in need of addressing before planning for a flight of any length. <br /> <br /> In flight emergency medical equipment that may or may not be present on any particular flight varies by airline and country. Thus, one or more of the following may be available on a given flight:<br /> <br /> Emergency Medical Kit (required on all US-based airlines) includes:</p> <p>&nbsp;</p> <ul>   <li>Item / Quantity</li>   <li>Sphygmomanometer / 1</li>   <li>Stethoscope / 1</li>   <li>Oropharyngeal airways / 3 (3 sizes)</li>   <li>Syringes / 4 (different sizes, 2 sets)</li>   <li>Needles / 6 (different sizes, 2 sets)</li>   <li>50% dextrose injection, 50 ml. / 1</li>   <li>Epinephrine 1:1,000 single dose ampule / 2</li>   <li>Injectable diphen-hydramine (Benadyrl) single dose ampule / 2</li>   <li>Nitroglycerine tablets / 10</li>   <li>Instructions for use of medications / 1</li>   <li>Protective latex gloves or equivalent / 1 pair</li> </ul> <p>The emergency medical kit may only be opened during flight when authorized by a physician (on board or from the airline's medical department)<br /> <br /> Emergency First-Aid Kit: Contents are limited and intended for basic emergency care only.<br /> <br /> Automatic External Defibrillators: Now provided by a number of airlines along with flight personnel trained in their use.<br /> <br /> &quot;Enhanced&quot; Medical Kit: These upgraded medical kits have been installed by some airlines and contain a wide variety of acute cardiac life support drugs and equipment.<br /> <br /> Oxygen: Supplemental oxygen is available on an emergency basis only. (Flow rates vary from 2 to 8L per minute). There is a fee for this service which usually requires a minimum of 24 to 48 hours advanced notice as well as a medical certificate certifying the passenger is cleared to fly at a relative cabin altitude of 8,000 feet and specifying the flow rate and type delivery mask to be used. (Note: passengers cannot bring their own oxygen on board).<br /> <br /> Respiratory equipment: Other equipment such as nebulizers and pediatric mechanical ventilators may be used on board, but must be pre-approved to prevent interference with sensitive electronic aviation equipment and must comply with applicable Federal Air Regulations (FARs).<br /> <br /> One of the most serious medical reasons for avoiding air travel is pre-existing cardiovascular problems. The following cardiovascular conditions are generally regarded as contraindicated to commercial airline flight according to the Aerospace Medical Association guidelines (1997) and a number of airline informational handouts:<br /> </p> <ul>   <li>Uncomplicated myocardial infarction occurring with three weeks of flight;</li>   <li>Complicated myocardial infarction occurring with six weeks of flight;</li>   <li>Unstable angina;</li>   <li>Severe, decompensated congestive heart failure;</li>   <li>Uncontrolled hypertension;</li>   <li>Coronary artery bypass grafting performed with two weeks of flight;</li>   <li>Cardiovascular accident occurring within two weeks of flight;</li>   <li>Uncontrolled ventricular or supraventricular tachycardia;</li>   <li>Eisenmenger's syndrome;</li>   <li>Severe symptomatic valvular heart disease.</li> </ul> <p>There are some basic procedures and preparations that passengers with various forms of cardiac disease can take before flying:<br /> </p> <ul>   <li>Have a sufficient supply of all cardiac medications (in a labeled container) and keep them in carry-on luggage;</li>   <li>Carry a copy of most recent electrocardiogram;</li>   <li>While pacemakers and implanted cardiac devices are not affected by airport security devices, any new or unfamiliar implanted devices should be cleared for inspection by the manufacturer;</li>   <li>Arrange for supplemental oxygen during flight if needed;</li> </ul> <p>Diabetics will avoid most problems if they follow a few simple rules before flying:<br /> </p> <ul>   <li>Pack twice as much medications and supplies as needed. One half of this should be kept in a carry-on bag;</li>   <li>Written instructions for administration of medications should be carried in carry-on bag;</li>   <li>Blood testing equipment (including an extra battery for glucose meter) should be kept in carry-on bag;</li>   <li>Passenger should carry personal identification card, diabetes identification card, personal physician's business card, a set of prescriptions (to be filled in the event medications are lost or stolen), glucose tablets, or another form of sugar to treat low blood sugar).</li> </ul> <p>Pregnant women are generally advised not to fly when approaching their expected delivery date. Even brief flights are not recommended within one week of expected delivery. This is to avoid in-flight deliveries rather than to guard against any harm to the fetus.<br /> <br /> Pregnant women should request an aisle seat in order to stretch their legs and walk about the cabin as much as possible. Isometric leg exercises are also advised, especially during extended flights.<br /> <br /> Seat belts should be worn whenever seated and the belt should be positioned low around the pelvis to reduce the possibility of fetal injury. <br /> <br /> Pregnant women should also be aware of the potential for dehydration (due to low cabin humidity), motion sickness, and gastrointestinal discomfort. <br /> <br /> Availability of medical care and insurance coverage at the point of destination should be checked in advance.<br /> <br /> Finally, any woman with a history of complicated pregnancies or complicating factors for the current pregnancy should not fly.<br /> <br /> People suffering from conditions such as middle ear infections, effusions, sinusitis or allergies or infections creating nasal congestion, should check with their physician before flying. </p> <p>Congestion should be controlled as much as possible to avoid simple (pain) or severe (rupture of tympanic membrane) complications.<br /> <br /> Those having undergone recent surgery involving the inner or middle ear should not fly.<br /> <br /> Simple ear problems can usually be controlled or alleviated by the use of decongestants or effective Valsalva maneuver (closing the nose with the thumb and index finger and exhaling gently with the mouth closed), chewing gum and frequent swallowing. <br /> <br /> Infants should be given a bottle or pacifier to avoid discomfort, especially during take-off and landing.<br /> <br /> All potential passengers who have recently undergone any surgical procedure should check with their doctor before flying. <br /> <br /> In certain situations, a physician's certificate may be required before flying.<br /> <br /> Many types of surgery such as abdominal, neurological, laparoscopic, ophthalmologic, and thoracic, are associated with pressure related problems caused by the expansion of trapped gases.<br /> <br /> Other conditions requiring attention: <br /> <br /> Scuba divers - should wait 12 hours (1 dive per day) to 24 hours (multiple or deep dives) before flying.<br /> <br /> Jet lag (physiologic reaction to traveling long distances in short periods of time) some suggestions include:<br /> </p> <ul>   <li>Sleep well before beginning trip;</li>   <li>Keep sleep amounts (in a 24 hour period) the same as at home;</li>   <li>Avoid excessive alcohol;</li>   <li>Avoid overeating;</li>   <li>Attempt to stay on home time;</li>   <li>Adjust as quickly as possible to new time zone;</li>   <li>Moderate exercise;</li>   <li>Limit use of sleep medications</li> </ul> Orthopedic injuries: Use bi-valve casts to avoid circulatory problems. Keep extremely elevated. Before flight, release air from pneumatic splints (if allowed).<br /> <br /> Epilepsy: Wear identification bracelet or other easily found epilepsy identification. Carry anti-epileptic medications in carry-on luggage. Discuss a temporary small increase in medication with your doctor.<br /> <br /> Psychiatric conditions: Avoid alcohol and consider using a mild sedative. Notify airline in advance. Travel with a responsible companion if possible. (Note: In 2005 a man with psychiatric problems was shot to death by an air marshal when he behaved irrationally just before his flight took off. Although he was accompanied by his wife, events unfolded so quickly that the tragedy could not be averted. Thus, anyone with a psychiatric condition that might present unusual behavior should be discussed ahead of time with the airline and flight crew. With enhanced post-9/11 security, it is better to be safe than sorry.) &nbsp;<br /> <br /> Medical devices with pneumatic components such as feeding tubes, pneumatic splints, urinary catheters and other closed infusion devices should be capped off during take-offs and landings.<br /> <br /> Dehydration: Since cabin humidity levels are usually less than 25%, passengers often experience dryness in the eyes, nose, and throat. Contact lens wearers can experience irritation. Suggestions for dealing with these problems include:<br /> <ul>   <li>Avoid alcohol, coffee, tea, and other diuretics;</li>   <li>Drink water or juices frequently;</li>   <li>Wear glasses instead of contact lenses if possible;</li>   <li>Use a skin moisturizer</li> </ul> Motion sickness: Can be brought on by turbulence or staring at moving objects. Over-the-counter and prescription medications are usually effective. You should consult your doctor, however, in this regard. <br /> <br /> Non-medication suggestions include pressure bands, keeping your eyes fixed on a non-moving object and looking at the ground, sea or horizon if possible.<br /> <br /> Muscle problems: These include tension, fatigue, aches, and stiffness. Recommendations include walking about the cabin occasionally, doing exercises such as ankle circles, foot pumps, knees lifts, shoulder rolls and knee to chest, for 3-4 minutes every hour if possible.<br /> <br /> Clearly, while air travel is one of the safest means of transportation, it presents some conditions that are not found at ground level or where there is access to outside air. <br /> <br /> Thus, cabin pressure, decreased oxygen levels, potential air pollution (chemical, particle, and bacterial), restrictive seating, limited mobility, inability to obtain immediate emergency medical care, limited access to medical equipment and medications, stress, and psychiatric conditions that may be triggered or aggravated by confined quarters or stress requires that passengers anticipate medical contingencies that may affect them or a person traveling with them.&nbsp; <br /> ]]></content:encoded>
	</item>	
	
	<item>
		<title>New air travel clot risk theory</title>
		<link>http://www.yourlawyer.com/articles/read/11471</link>		
		<pubDate>Fri, 10 Mar 2006 00:00:00 -0800</pubDate>
		<dc:creator></dc:creator>		
		<guid isPermaLink="false">http://www.yourlawyer.com/articles/read/11471</guid>
		<description><![CDATA[Sitting still for long periods cannot alone explain why air passengers are at higher risk of potentially deadly blood clots, research suggests.  The risk of developing deep vein thrombosis is thought to be raised by air travel - particularly long flights.  But a Lancet study by Dutch researchers found chemicals indicating clotting in 71 volunteers were higher during eight hours on a flight than in the cinema.  It suggests low air pressure and...]]></description>
			<content:encoded><![CDATA[Sitting still for long periods cannot alone explain why air passengers are at higher risk of potentially deadly blood clots, research suggests.<br /> <br /> The risk of developing deep vein thrombosis is thought to be raised by air travel - particularly long flights.<br /> <br /> But a Lancet study by Dutch researchers found chemicals indicating clotting in 71 volunteers were higher during eight hours on a flight than in the cinema.<br /> <br /> It suggests low air pressure and oxygen levels on a flight may play a role.<br /> <br /> Deep vein thrombosis (DVT) occurs when blood passing through the deepest veins in the calf or thigh flows so slowly that a solid clot forms.<br /> <br /> DVTs themselves are not life-threatening but they are associated with complications which can be fatal.<br /> <br /> For instance, a piece of the clot can break off, and become lodged in the lungs, resulting in a potentially fatal pulmonary embolism.<br /> <br /> A team from Leiden University Medical Centre measured levels of chemicals indicating clotting activity in 71 healthy volunteers before, during and immediately after an eight-hour flight.<br /> <br /> They also compared the concentrations in the same individuals at the same time points during eight hours of sitting in a cinema and eight hours of regular daily activities.<br /> <br /> Four out of 10 participants carried a gene that put them at increased risk of thrombosis.<br /> <br /> The results showed increased concentrations of the chemicals during the flight compared to the other two situations - especially in volunteers with other risk factors for thrombosis.<br /> <br /> Other factors<br /> <br /> Lead researcher Professor Frits Rosendaal told the BBC News Website that immobilisation during a long flight was still likely to be the most significant risk factor.<br /> <br /> But he said: &quot;Our study suggests it is not just immobilisation, there is something else that adds to the risk when you are in the air that does not exist when you are sitting down for a long time while on the ground.&quot;<br /> <br /> Professor Rosendaal said low air pressure, and oxygen levels were the most likely candidates, but he said it was impossible to rule out other potential factors, such as stress or air pollution.<br /> <br /> Mr John Scurr, a consultant general and vascular surgeon at the Lister Hospital in London, said previous studies into the possibe impact of low oxygen and air pressure levels on the likelihood of developing clots had produced mixed results.<br /> <br /> &quot;Currently the only evidence we have is that immobility is the most important factor, but a number of us have suspected for a long time that there must be other factors having an effect.&quot;<br /> <br /> Mr Scurr said a much larger study was required to provide definitive answers.<br /> <br /> However, he stressed the risk to the travelling public was low and that there were common sense measures that could minimise that risk still further. <br />]]></content:encoded>
	</item>	
	
	<item>
		<title>DVT Ortho Evra Side Effects</title>
		<link>http://www.yourlawyer.com/topics/overview/deep_vein_thrombosis</link>		
		<pubDate>Fri, 10 Mar 2006 00:00:00 -0800</pubDate>
		<dc:creator></dc:creator>		
		<guid isPermaLink="false">http://www.yourlawyer.com/topics/overview/deep_vein_thrombosis</guid>
		<description><![CDATA[Deep Vein Thrombosis (DVT)In recent months, the birth control patch Ortho-Evra has been linked to blood clots and deep vein thrombosis (DVT). In July 2005, a major news source published their own findings indicating Ortho Evra patch use can triple a patient&rsquo;s risk of encountering deep vein thrombosis&nbsp; (DVT) symptoms or other serious side effects.The women using the birth control patch who developed deep vein thrombosis (DVT) symptoms,...]]></description>
			<content:encoded><![CDATA[<p><strong>Deep Vein Thrombosis (DVT)</strong><br /><br />In recent months, the birth control patch Ortho-Evra has been linked to blood clots and deep vein thrombosis (DVT). In July 2005, a major news source published their own findings indicating Ortho Evra patch use can triple a patient&rsquo;s risk of encountering deep vein thrombosis&nbsp; (DVT) symptoms or other serious side effects.<br /><br />The women using the birth control patch who developed deep vein thrombosis (DVT) symptoms, some have died as a result of life threatening complications. Other studies have illustrated that using the Ortho Evra birth control patch may cause a woman to develop deep vein thrombosis (DVT) symptoms independent of other blood clot risk factors. Deep vein thrombosis (DVT)can lead to a very serious and life threatening condition called pulmonary embolism, when the blood clot breaks away and travels to the lungs.<br /><br />Prior to approval, the FDA medical review expressed concerns about Ortho Evra causing venous thromboembolisms, stating: &ldquo;Post-marketing surveillance for DVT (Deep Vein Thrombosis) and PE (Pulmonary Embolism) events will be important, as there are potential serious adverse risks (with two cases of pulmonary emboli in the clinical trials) with this new delivery system for contraception.&rdquo;<br /><br />Pateints who take or have taken Vioxx are at an increased risk of developing pulmonary embolism (PE) and deep vein thrombosis (DVT). Vioxx promotes the formation of blood clots, which can then cause pulmonary embolism (PE) and can then result in deep vein thrombosis (DVT) symptoms.<br /><br />Deep vein thrombosis (DVT) is the progression of a blood clot (thrombus) in the deep veins of the legs, arms, or pelvis. Clots can develop in superficial veins (called superficial thrombophlebitis) and in deep veins. Blood clots in superficial veins rarely cause serious problems, and clots in deep veins require immediate medical evaluation.<br /><br />Deep vein blood clots can grow in size, break loose, and then travel through the bloodstream to the lungs, resulting in life-threatening pulmonary embolism. Deep vein thrombosis may also cause other long-term complications. In approximately 25% of cases, deep vein thrombosis damages the affected vein and leads to long-lasting postthrombotic syndrome. This condition causes pain, swelling, discoloration, and leg sores.<br /><br />Blood clots can form in veins when you are inactive: for instance, if you are paralyzed, bedridden, or even during a long flight or car trip. Surgery or an injury can damage your blood vessels and cause a clot to form. Deep vein thrombosis can also be caused by cancer or an inherited tendency to clot more quickly.<br /><br />Prior to approval, the FDA medical review expressed concerns about Ortho Evra causing venous thromboembolisms, stating: &ldquo;Post-marketing surveillance for DVT (Deep Vein Thrombosis) and PE (Pulmonary Embolism) events will be important, as there are potential serious adverse risks (with two cases of pulmonary emboli in the clinical trials) with this new delivery system for contraception.&rdquo;<br /><br />Symptoms of deep vein thrombosis include generalized swelling of the affected leg. When measured, the affected leg may be larger than the other leg. Also, your affected leg may feel warm and be redder than the other leg. You may have pain or tenderness in the calf or thigh when it is touched or squeezed or with movement or standing. Calf or thigh pain may become constant and increase with squeezing or movement.<br /><br />If a deep vein thrombus is small, it may not cause symptoms. In some cases, pulmonary embolism is the first sign that you have deep vein thrombosis.</p>
<p>If you or a loved one has been diagnosed with Deep vein thrombosis as a result of taking HRT drugs, COX-II Inhibitors or the Ortho Evra Patch, please fill out the form at the right for a free case evaluation by a qualified defective drug attorney.</p>]]></content:encoded>
	</item>	
		
	</channel>
</rss>